MovDisordV3, PascalFrancis, Corpus, bibRecord, 000499

Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations

Identifieur interne : 000499 ( PascalFrancis/Corpus ); précédent : 000498; suivant : 000500

Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations

Auteurs : Michele Tagliati ; Paul Krack ; Jens Volkmann ; Tipu Aziz ; Joachim K. Krauss ; Andreas Kupsch ; Marie Vidailhet

Source :

Movement disorders [ 0885-3185 ] ; 2011.

RBID : Pascal:11-0356324

Descripteurs français

Pascal (Inist)
- Dystonie, Pathologie du système nerveux, Long terme, Conduite à tenir, Complication.

English descriptors

KwdEn :
- Clinical management, Complication, Dystonia, Long term, Nervous system diseases.

Abstract

Multiple independent case series have documented sustained benefit of bilateral pallidal deep brain stimulation (DBS) up to 3 years in patients with primary dystonia. Growing evidence exists for positive outcomes extending up to 10 years. The beneficial effects from DBS are usually reported to be stable, thus requiring little long-term modifications of the parameters of stimulation. Speech and swallowing abnormalities are less responsive than other dystonic symptoms. Symptom exacerbation after initial benefit has been reported in a few cases. It is not known whether this is related to potential tolerance or habituation to stimulation or to progression of the underlying disease. Failures of pallidal DBS, at least in primary dystonia patients, should not be accepted without further re-evaluation of each individual case, including possible revisions of the electrode location. Both hardware- and stimulation-related adverse effects, including insufficient relief of speech function, have been reported in the long-term. Despite early reports suggesting that hardware problems might be more frequent in dystonia, more recent studies did not confirm these observations. In patients with severe segmental (e.g., axial) or generalized dystonia, sudden cessation of stimulation may become a medical emergency and should be anticipated changing the neurostimulator before its natural end of life.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 26`
A06				`@2 7 @3 SUP`
A08	`01`	`1`	`ENG`	`@1 Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations`
A09	`01`	`1`	`ENG`	`@1 Deep Brain Stimulation for Dystonia: The State of the Art`
A11	`01`	`1`		`@1 TAGLIATI (Michele)`
A11	`02`	`1`		`@1 KRACK (Paul)`
A11	`03`	`1`		`@1 VOLKMANN (Jens)`
A11	`04`	`1`		`@1 AZIZ (Tipu)`
A11	`05`	`1`		`@1 KRAUSS (Joachim K.)`
A11	`06`	`1`		`@1 KUPSCH (Andreas)`
A11	`07`	`1`		`@1 VIDAILHET (Marie)`
A12	`01`	`1`		`@1 MORO (Elena) @9 ed.`
A12	`02`	`1`		`@1 ALBANESE (Alberto) @9 ed.`
A12	`03`	`1`		`@1 HARIZ (Marwan I.) @9 ed.`
A12	`04`	`1`		`@1 KRAUSS (Joachim K.) @9 ed.`
A12	`05`	`1`		`@1 VERHAGEN METMAN (Leo) @9 ed.`
A12	`06`	`1`		`@1 VIDAILHET (Marie) @9 ed.`
A14	`01`			`@1 Department of Neurology, Cedars-Sinai Medical Center @2 Los Angeles, California @3 USA @Z 1 aut.`
A14	`02`			`@1 Service de Neurologie, Joseph Fourier University @2 Grenoble @3 FRA @Z 2 aut.`
A14	`03`			`@1 Department of Neurology, University of Wurzburg @3 DEU @Z 3 aut.`
A14	`04`			`@1 Department of Neurosurgery, John Radcliffe Hospital @2 Oxford @3 GBR @Z 4 aut.`
A14	`05`			`@1 Department of Neurosurgery, Medical University, MHH @2 Hannover @3 DEU @Z 5 aut.`
A14	`06`			`@1 Division of Neurology, Charité, Campus Virchow @2 Berlin @3 DEU @Z 6 aut.`
A14	`07`			`@1 Department of Neurology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, F-7513, CRICM, CNRS UMR 7225, UPMC Université Paris 6/Inserm UMR_S 975 @2 Paris @3 FRA @Z 7 aut.`
A15	`01`			`@1 Movement Disorders Center, Division of Neurology, Toronto Western hospital, University of Toronto, UHN @2 Toronto, Ontario @3 CAN @Z 1 aut.`
A15	`02`			`@1 Istituto Neurologico Carlo Besta and Università Cattolica @2 Milano @3 ITA @Z 2 aut.`
A15	`03`			`@1 Department of Neurological Sciences, Rush University Medical Center @2 Chicago, Illinois @3 USA`
A15	`04`			`@1 Hôpital de la Salpetrière, Fédération de Neurologie, CRICM UPMC/INSERM UMR-S 975, UPMC/CNRS UMR 7225 @2 Paris @3 FRA @Z 5 aut. @Z 6 aut.`
A15	`05`			`@1 Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square @2 London @3 GBR @Z 3 aut.`
A15	`06`			`@1 Department of Neurosurgery, Medical University, MHH @2 Hannover @3 DEU @Z 4 aut.`
A20				`@2 S58-S67`
A21				`@1 2011`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000190458070060`
A44				`@0 0000 @1 © 2011 INIST-CNRS. All rights reserved.`
A45				`@0 50 ref.`
A47	`01`	`1`		`@0 11-0356324`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Multiple independent case series have documented sustained benefit of bilateral pallidal deep brain stimulation (DBS) up to 3 years in patients with primary dystonia. Growing evidence exists for positive outcomes extending up to 10 years. The beneficial effects from DBS are usually reported to be stable, thus requiring little long-term modifications of the parameters of stimulation. Speech and swallowing abnormalities are less responsive than other dystonic symptoms. Symptom exacerbation after initial benefit has been reported in a few cases. It is not known whether this is related to potential tolerance or habituation to stimulation or to progression of the underlying disease. Failures of pallidal DBS, at least in primary dystonia patients, should not be accepted without further re-evaluation of each individual case, including possible revisions of the electrode location. Both hardware- and stimulation-related adverse effects, including insufficient relief of speech function, have been reported in the long-term. Despite early reports suggesting that hardware problems might be more frequent in dystonia, more recent studies did not confirm these observations. In patients with severe segmental (e.g., axial) or generalized dystonia, sudden cessation of stimulation may become a medical emergency and should be anticipated changing the neurostimulator before its natural end of life.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17H`
C03	`01`	`X`	`FRE`	`@0 Dystonie @5 01`
C03	`01`	`X`	`ENG`	`@0 Dystonia @5 01`
C03	`01`	`X`	`SPA`	`@0 Distonía @5 01`
C03	`02`	`X`	`FRE`	`@0 Pathologie du système nerveux @5 02`
C03	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 02`
C03	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 02`
C03	`03`	`X`	`FRE`	`@0 Long terme @5 09`
C03	`03`	`X`	`ENG`	`@0 Long term @5 09`
C03	`03`	`X`	`SPA`	`@0 Largo plazo @5 09`
C03	`04`	`X`	`FRE`	`@0 Conduite à tenir @5 10`
C03	`04`	`X`	`ENG`	`@0 Clinical management @5 10`
C03	`04`	`X`	`SPA`	`@0 Actitud médica @5 10`
C03	`05`	`X`	`FRE`	`@0 Complication @5 11`
C03	`05`	`X`	`ENG`	`@0 Complication @5 11`
C03	`05`	`X`	`SPA`	`@0 Complicación @5 11`
C07	`01`	`X`	`FRE`	`@0 Syndrome extrapyramidal @5 37`
C07	`01`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 37`
C07	`01`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 37`
C07	`02`	`X`	`FRE`	`@0 Mouvement involontaire @5 38`
C07	`02`	`X`	`ENG`	`@0 Involuntary movement @5 38`
C07	`02`	`X`	`SPA`	`@0 Movimiento involuntario @5 38`
C07	`03`	`X`	`FRE`	`@0 Pathologie du muscle strié @5 39`
C07	`03`	`X`	`ENG`	`@0 Striated muscle disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Músculo estriado patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Trouble neurologique @5 41`
C07	`04`	`X`	`ENG`	`@0 Neurological disorder @5 41`
C07	`04`	`X`	`SPA`	`@0 Trastorno neurológico @5 41`
C07	`05`	`X`	`FRE`	`@0 Pathologie de l'encéphale @5 42`
C07	`05`	`X`	`ENG`	`@0 Cerebral disorder @5 42`
C07	`05`	`X`	`SPA`	`@0 Encéfalo patología @5 42`
C07	`06`	`X`	`FRE`	`@0 Pathologie du système nerveux central @5 43`
C07	`06`	`X`	`ENG`	`@0 Central nervous system disease @5 43`
C07	`06`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 43`
N21				`@1 241`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 11-0356324 INIST
ET :	Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations
AU :	TAGLIATI (Michele); KRACK (Paul); VOLKMANN (Jens); AZIZ (Tipu); KRAUSS (Joachim K.); KUPSCH (Andreas); VIDAILHET (Marie); MORO (Elena); ALBANESE (Alberto); HARIZ (Marwan I.); KRAUSS (Joachim K.); VERHAGEN METMAN (Leo); VIDAILHET (Marie)
AF :	Department of Neurology, Cedars-Sinai Medical Center/Los Angeles, California/Etats-Unis (1 aut.); Service de Neurologie, Joseph Fourier University/Grenoble/France (2 aut.); Department of Neurology, University of Wurzburg/Allemagne (3 aut.); Department of Neurosurgery, John Radcliffe Hospital/Oxford/Royaume-Uni (4 aut.); Department of Neurosurgery, Medical University, MHH/Hannover/Allemagne (5 aut.); Division of Neurology, Charité, Campus Virchow/Berlin/Allemagne (6 aut.); Department of Neurology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, F-7513, CRICM, CNRS UMR 7225, UPMC Université Paris 6/Inserm UMR_S 975/Paris/France (7 aut.); Movement Disorders Center, Division of Neurology, Toronto Western hospital, University of Toronto, UHN/Toronto, Ontario/Canada (1 aut.); Istituto Neurologico Carlo Besta and Università Cattolica/Milano/Italie (2 aut.); Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis; Hôpital de la Salpetrière, Fédération de Neurologie, CRICM UPMC/INSERM UMR-S 975, UPMC/CNRS UMR 7225/Paris/France (5 aut., 6 aut.); Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square/London/Royaume-Uni (3 aut.); Department of Neurosurgery, Medical University, MHH/Hannover/Allemagne (4 aut.)
DT :	Publication en série; Niveau analytique
SO :	Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 7 SUP; S58-S67; Bibl. 50 ref.
LA :	Anglais
EA :	Multiple independent case series have documented sustained benefit of bilateral pallidal deep brain stimulation (DBS) up to 3 years in patients with primary dystonia. Growing evidence exists for positive outcomes extending up to 10 years. The beneficial effects from DBS are usually reported to be stable, thus requiring little long-term modifications of the parameters of stimulation. Speech and swallowing abnormalities are less responsive than other dystonic symptoms. Symptom exacerbation after initial benefit has been reported in a few cases. It is not known whether this is related to potential tolerance or habituation to stimulation or to progression of the underlying disease. Failures of pallidal DBS, at least in primary dystonia patients, should not be accepted without further re-evaluation of each individual case, including possible revisions of the electrode location. Both hardware- and stimulation-related adverse effects, including insufficient relief of speech function, have been reported in the long-term. Despite early reports suggesting that hardware problems might be more frequent in dystonia, more recent studies did not confirm these observations. In patients with severe segmental (e.g., axial) or generalized dystonia, sudden cessation of stimulation may become a medical emergency and should be anticipated changing the neurostimulator before its natural end of life.
CC :	002B17; 002B17H
FD :	Dystonie; Pathologie du système nerveux; Long terme; Conduite à tenir; Complication
FG :	Syndrome extrapyramidal; Mouvement involontaire; Pathologie du muscle strié; Trouble neurologique; Pathologie de l'encéphale; Pathologie du système nerveux central
ED :	Dystonia; Nervous system diseases; Long term; Clinical management; Complication
EG :	Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Central nervous system disease
SD :	Distonía; Sistema nervioso patología; Largo plazo; Actitud médica; Complicación
LO :	INIST-20953.354000190458070060
ID :	11-0356324

Links to Exploration step

Pascal:11-0356324

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations</title>
<author><name sortKey="Tagliati, Michele" sort="Tagliati, Michele" uniqKey="Tagliati M" first="Michele" last="Tagliati">Michele Tagliati</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Cedars-Sinai Medical Center</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krack, Paul" sort="Krack, Paul" uniqKey="Krack P" first="Paul" last="Krack">Paul Krack</name>
<affiliation><inist:fA14 i1="02"><s1>Service de Neurologie, Joseph Fourier University</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Volkmann, Jens" sort="Volkmann, Jens" uniqKey="Volkmann J" first="Jens" last="Volkmann">Jens Volkmann</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Wurzburg</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Aziz, Tipu" sort="Aziz, Tipu" uniqKey="Aziz T" first="Tipu" last="Aziz">Tipu Aziz</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurosurgery, John Radcliffe Hospital</s1>
<s2>Oxford</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krauss, Joachim K" sort="Krauss, Joachim K" uniqKey="Krauss J" first="Joachim K." last="Krauss">Joachim K. Krauss</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurosurgery, Medical University, MHH</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kupsch, Andreas" sort="Kupsch, Andreas" uniqKey="Kupsch A" first="Andreas" last="Kupsch">Andreas Kupsch</name>
<affiliation><inist:fA14 i1="06"><s1>Division of Neurology, Charité, Campus Virchow</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Neurology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, F-7513, CRICM, CNRS UMR 7225, UPMC Université Paris 6/Inserm UMR_S 975</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0356324</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0356324 INIST</idno>
<idno type="RBID">Pascal:11-0356324</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000499</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations</title>
<author><name sortKey="Tagliati, Michele" sort="Tagliati, Michele" uniqKey="Tagliati M" first="Michele" last="Tagliati">Michele Tagliati</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Cedars-Sinai Medical Center</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krack, Paul" sort="Krack, Paul" uniqKey="Krack P" first="Paul" last="Krack">Paul Krack</name>
<affiliation><inist:fA14 i1="02"><s1>Service de Neurologie, Joseph Fourier University</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Volkmann, Jens" sort="Volkmann, Jens" uniqKey="Volkmann J" first="Jens" last="Volkmann">Jens Volkmann</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Wurzburg</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Aziz, Tipu" sort="Aziz, Tipu" uniqKey="Aziz T" first="Tipu" last="Aziz">Tipu Aziz</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurosurgery, John Radcliffe Hospital</s1>
<s2>Oxford</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Krauss, Joachim K" sort="Krauss, Joachim K" uniqKey="Krauss J" first="Joachim K." last="Krauss">Joachim K. Krauss</name>
<affiliation><inist:fA14 i1="05"><s1>Department of Neurosurgery, Medical University, MHH</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kupsch, Andreas" sort="Kupsch, Andreas" uniqKey="Kupsch A" first="Andreas" last="Kupsch">Andreas Kupsch</name>
<affiliation><inist:fA14 i1="06"><s1>Division of Neurology, Charité, Campus Virchow</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation><inist:fA14 i1="07"><s1>Department of Neurology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, F-7513, CRICM, CNRS UMR 7225, UPMC Université Paris 6/Inserm UMR_S 975</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clinical management</term>
<term>Complication</term>
<term>Dystonia</term>
<term>Long term</term>
<term>Nervous system diseases</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Dystonie</term>
<term>Pathologie du   système nerveux</term>
<term>Long terme</term>
<term>Conduite à tenir</term>
<term>Complication</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multiple independent case series have documented sustained benefit of bilateral pallidal deep brain stimulation (DBS) up to 3 years in patients with primary dystonia. Growing evidence exists for positive outcomes extending up to 10 years. The beneficial effects from DBS are usually reported to be stable, thus requiring little long-term modifications of the parameters of stimulation. Speech and swallowing abnormalities are less responsive than other dystonic symptoms. Symptom exacerbation after initial benefit has been reported in a few cases. It is not known whether this is related to potential tolerance or habituation to stimulation or to progression of the underlying disease. Failures of pallidal DBS, at least in primary dystonia patients, should not be accepted without further re-evaluation of each individual case, including possible revisions of the electrode location. Both hardware- and stimulation-related adverse effects, including insufficient relief of speech function, have been reported in the long-term. Despite early reports suggesting that hardware problems might be more frequent in dystonia, more recent studies did not confirm these observations. In patients with severe segmental (e.g., axial) or generalized dystonia, sudden cessation of stimulation may become a medical emergency and should be anticipated changing the neurostimulator before its natural end of life.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>26</s2>
</fA05>
<fA06><s2>7</s2>
<s3>SUP</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Deep Brain Stimulation for Dystonia: The State of the Art</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>TAGLIATI (Michele)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>KRACK (Paul)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>VOLKMANN (Jens)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>AZIZ (Tipu)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>KRAUSS (Joachim K.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>KUPSCH (Andreas)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>VIDAILHET (Marie)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>MORO (Elena)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>ALBANESE (Alberto)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="03" i2="1"><s1>HARIZ (Marwan I.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="04" i2="1"><s1>KRAUSS (Joachim K.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="05" i2="1"><s1>VERHAGEN METMAN (Leo)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="06" i2="1"><s1>VIDAILHET (Marie)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Department of Neurology, Cedars-Sinai Medical Center</s1>
<s2>Los Angeles, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Service de Neurologie, Joseph Fourier University</s1>
<s2>Grenoble</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, University of Wurzburg</s1>
<s3>DEU</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Neurosurgery, John Radcliffe Hospital</s1>
<s2>Oxford</s2>
<s3>GBR</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Neurosurgery, Medical University, MHH</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Division of Neurology, Charité, Campus Virchow</s1>
<s2>Berlin</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Neurology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, F-7513, CRICM, CNRS UMR 7225, UPMC Université Paris 6/Inserm UMR_S 975</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Movement Disorders Center, Division of Neurology, Toronto Western hospital, University of Toronto, UHN</s1>
<s2>Toronto, Ontario</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Istituto Neurologico Carlo Besta and Università Cattolica</s1>
<s2>Milano</s2>
<s3>ITA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="03"><s1>Department of Neurological Sciences, Rush University Medical Center</s1>
<s2>Chicago, Illinois</s2>
<s3>USA</s3>
</fA15>
<fA15 i1="04"><s1>Hôpital de la Salpetrière, Fédération de Neurologie, CRICM UPMC/INSERM UMR-S 975, UPMC/CNRS UMR 7225</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA15>
<fA15 i1="05"><s1>Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</fA15>
<fA15 i1="06"><s1>Department of Neurosurgery, Medical University, MHH</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>4 aut.</sZ>
</fA15>
<fA20><s2>S58-S67</s2>
</fA20>
<fA21><s1>2011</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000190458070060</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>50 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>11-0356324</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Multiple independent case series have documented sustained benefit of bilateral pallidal deep brain stimulation (DBS) up to 3 years in patients with primary dystonia. Growing evidence exists for positive outcomes extending up to 10 years. The beneficial effects from DBS are usually reported to be stable, thus requiring little long-term modifications of the parameters of stimulation. Speech and swallowing abnormalities are less responsive than other dystonic symptoms. Symptom exacerbation after initial benefit has been reported in a few cases. It is not known whether this is related to potential tolerance or habituation to stimulation or to progression of the underlying disease. Failures of pallidal DBS, at least in primary dystonia patients, should not be accepted without further re-evaluation of each individual case, including possible revisions of the electrode location. Both hardware- and stimulation-related adverse effects, including insufficient relief of speech function, have been reported in the long-term. Despite early reports suggesting that hardware problems might be more frequent in dystonia, more recent studies did not confirm these observations. In patients with severe segmental (e.g., axial) or generalized dystonia, sudden cessation of stimulation may become a medical emergency and should be anticipated changing the neurostimulator before its natural end of life.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17H</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Dystonie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Dystonia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Distonía</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Pathologie du   système nerveux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Long terme</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Long term</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Largo plazo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Conduite à tenir</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Clinical management</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Actitud médica</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Complication</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Complication</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Complicación</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie du muscle strié</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Striated muscle disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Músculo estriado patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>42</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Pathologie du   système nerveux central</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>43</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>43</s5>
</fC07>
<fN21><s1>241</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 11-0356324 INIST</NO>
<ET>Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations</ET>
<AU>TAGLIATI (Michele); KRACK (Paul); VOLKMANN (Jens); AZIZ (Tipu); KRAUSS (Joachim K.); KUPSCH (Andreas); VIDAILHET (Marie); MORO (Elena); ALBANESE (Alberto); HARIZ (Marwan I.); KRAUSS (Joachim K.); VERHAGEN METMAN (Leo); VIDAILHET (Marie)</AU>
<AF>Department of Neurology, Cedars-Sinai Medical Center/Los Angeles, California/Etats-Unis (1 aut.); Service de Neurologie, Joseph Fourier University/Grenoble/France (2 aut.); Department of Neurology, University of Wurzburg/Allemagne (3 aut.); Department of Neurosurgery, John Radcliffe Hospital/Oxford/Royaume-Uni (4 aut.); Department of Neurosurgery, Medical University, MHH/Hannover/Allemagne (5 aut.); Division of Neurology, Charité, Campus Virchow/Berlin/Allemagne (6 aut.); Department of Neurology, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, F-7513, CRICM, CNRS UMR 7225, UPMC Université Paris 6/Inserm UMR_S 975/Paris/France (7 aut.); Movement Disorders Center, Division of Neurology, Toronto Western hospital, University of Toronto, UHN/Toronto, Ontario/Canada (1 aut.); Istituto Neurologico Carlo Besta and Università Cattolica/Milano/Italie (2 aut.); Department of Neurological Sciences, Rush University Medical Center/Chicago, Illinois/Etats-Unis; Hôpital de la Salpetrière, Fédération de Neurologie, CRICM UPMC/INSERM UMR-S 975, UPMC/CNRS UMR 7225/Paris/France (5 aut., 6 aut.); Unit of Functional Neurosurgery, UCL Institute of Neurology, Queen Square/London/Royaume-Uni (3 aut.); Department of Neurosurgery, Medical University, MHH/Hannover/Allemagne (4 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2011; Vol. 26; No. 7 SUP; S58-S67; Bibl. 50 ref.</SO>
<LA>Anglais</LA>
<EA>Multiple independent case series have documented sustained benefit of bilateral pallidal deep brain stimulation (DBS) up to 3 years in patients with primary dystonia. Growing evidence exists for positive outcomes extending up to 10 years. The beneficial effects from DBS are usually reported to be stable, thus requiring little long-term modifications of the parameters of stimulation. Speech and swallowing abnormalities are less responsive than other dystonic symptoms. Symptom exacerbation after initial benefit has been reported in a few cases. It is not known whether this is related to potential tolerance or habituation to stimulation or to progression of the underlying disease. Failures of pallidal DBS, at least in primary dystonia patients, should not be accepted without further re-evaluation of each individual case, including possible revisions of the electrode location. Both hardware- and stimulation-related adverse effects, including insufficient relief of speech function, have been reported in the long-term. Despite early reports suggesting that hardware problems might be more frequent in dystonia, more recent studies did not confirm these observations. In patients with severe segmental (e.g., axial) or generalized dystonia, sudden cessation of stimulation may become a medical emergency and should be anticipated changing the neurostimulator before its natural end of life.</EA>
<CC>002B17; 002B17H</CC>
<FD>Dystonie; Pathologie du   système nerveux; Long terme; Conduite à tenir; Complication</FD>
<FG>Syndrome extrapyramidal; Mouvement involontaire; Pathologie du muscle strié; Trouble neurologique; Pathologie de l'encéphale; Pathologie du   système nerveux central</FG>
<ED>Dystonia; Nervous system diseases; Long term; Clinical management; Complication</ED>
<EG>Extrapyramidal syndrome; Involuntary movement; Striated muscle disease; Neurological disorder; Cerebral disorder; Central nervous system disease</EG>
<SD>Distonía; Sistema nervioso patología; Largo plazo; Actitud médica; Complicación</SD>
<LO>INIST-20953.354000190458070060</LO>
<ID>11-0356324</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000499 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000499 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:11-0356324
   |texte=   Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations

Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri